© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
December 07, 2022
Drs Cerulli and Cutler discuss the data and pharmacological properties of amphetamine XR oral tablets.
Panelists discuss the use of amphetamine XR oral tablets in their practice and for which patients they’re using them.
November 30, 2022
Birgit H. Amann, MD, PLLC, discusses 2 recently approved treatment options for ADHD: amphetamine XR oral tablets and viloxazine.
Panelists discuss the importance of choosing treatments that are individualized to their patients.
Adults in US with Vision Impairment Reported Lower Access to Health Care Services
PRA023 Showing Promise in Both Crohn’s Disease, Ulcerative Colitis
Why Health Care Was Unprepared for the 2022 RSV Surge